Owner Revotar Biopharmaceuticals AG

Inventors Aydt, Ewald; Kranich, Remo

Agent Watermark

Pub. Number AU-B-2006299182

PCT Pub. Number WO2007/039112

Priority 05020509.5 20.09.05 EP

Filing date 20 September 2006

Wipo publication date 12 April 2007

Acceptance publication date 28 June 2012

C07D 213/30 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/191

A61K 31/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/381 - having five-membered rings

A61K 31/4418 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/4436

A61K 31/505 - Pyrimidines

A61K 31/5377

C07D 213/40 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/75 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/20 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 307/68 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/24 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms